MedTrace Logo

Ultrasound Classification and Grading of Lipohypertrophy and Its Impact on Glucose Variability in Type 1 Diabetes

NCT03669770 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2018-09-13

No results posted yet for this study

Summary

This study will use ultrasound to characterise lipohypertrophy(LH) and assess the impact of LH on glucose variability in adults with type 1 diabetes. LH is a condition that occurs with repeated exposure to insulin at injection sites, resulting in the development of subcutaneous fatty lumps that impede the absorption of insulin. LH can lead to glucose variability, increased risk of severe hypoglycaemia and diabetes distress. In the long term it can therefore lead to increased risk of diabetes complications and increased insulin costs.

Conditions

  • Lipohypertrophy
  • Type 1 Diabetes Mellitus

Sponsors & Collaborators

Principal Investigators

  • Angus Forbes, Professor · King's College London

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-22
Primary Completion
2018-04-25
Completion
2018-04-25

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03669770 on ClinicalTrials.gov